| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marilena Mangiardi, Guido Alfan. A clinical improvement of a idiopathic cervical dystonia in a patient treated with transdermal Rotigotine: a case-report. Acta bio-medica : Atenei Parmensis. vol 91. issue 3. 2021-06-25. PMID:32921774. |
furthermore, a dopamine agonist-response dystonia in patients with an autosomal recessive l-amino acid decarboxylase deficiency, has been described in the scientific literature. |
2021-06-25 |
2023-08-13 |
mouse |
| Marilena Mangiardi, Guido Alfan. A clinical improvement of a idiopathic cervical dystonia in a patient treated with transdermal Rotigotine: a case-report. Acta bio-medica : Atenei Parmensis. vol 91. issue 3. 2021-06-25. PMID:32921774. |
we report a case of focal cervical dystonia successful treated with a dopamine agonist (d3>d2>d1) rotigotine, a transdermal drug that induces a continuous dopaminergic stimulation. |
2021-06-25 |
2023-08-13 |
mouse |
| Yuning Liu, Hong Xing, Fumiaki Yokoi, David E Vaillancourt, Yuqing L. Investigating the role of striatal dopamine receptor 2 in motor coordination and balance: Insights into the pathogenesis of DYT1 dystonia. Behavioural brain research. vol 403. 2021-06-18. PMID:33476687. |
dyt1 dystonia patients show reduced striatal dopamine d2 receptor (d2r) binding activity. |
2021-06-18 |
2023-08-13 |
mouse |
| Jessica Qiu, Kishore Raj Kumar, Eloise Watson, Kate Ahmad, Carolyn M Sue, Michael W Haye. Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is Present. Journal of movement disorders. vol 14. issue 2. 2021-06-11. PMID:34062649. |
dystonia responsive to dopamine: polg mutations should be considered if sensory neuropathy is present. |
2021-06-11 |
2023-08-13 |
Not clear |
| Parvane Rashidpour, Zahra Poursharif, Mina Ayatollahi, Elham Farzanneja. Bupropion-induced acute dystonia in a patient with bulimia nervosa: A case report. Journal of family medicine and primary care. vol 10. issue 2. 2021-05-28. PMID:34041117. |
a physician who administers dopamine blocking agents must be aware of the prevalence of and the risk factors for acute dystonia and also the way of prevention and treatment. |
2021-05-28 |
2023-08-13 |
Not clear |
| Chiara Melis, Genevieve Beauvais, Brian S Muntean, Maria-Daniela Cirnaru, Garrett Otrimski, Jordi Creus-Muncunill, Kirill A Martemyanov, Pedro Gonzalez-Alegre, Michelle E Ehrlic. Striatal Dopamine Induced ERK Phosphorylation Is Altered in Mouse Models of Monogenic Dystonia. Movement disorders : official journal of the Movement Disorder Society. vol 36. issue 5. 2021-05-19. PMID:33458877. |
striatal dopamine induced erk phosphorylation is altered in mouse models of monogenic dystonia. |
2021-05-19 |
2023-08-13 |
mouse |
| Kazuyuki Togo, Toshiya Ishihara, Kenji Yamamoto, Hideyuki Sawad. Older-onset levodopa-responsive parkinsonism with normal DAT-SPECT and pterin hypometabolism. BMJ case reports. vol 14. issue 5. 2021-05-14. PMID:33962918. |
gtp cyclohydrolase 1 (gch-1) deficiency, which triggers pteridine hypometabolism and normally develops in childhood, can mediate an adult-onset decrease in levodopa production and dopa-responsive dystonia (drd), with normal dopamine transporter single-photon emission computed tomography (dat-spect). |
2021-05-14 |
2023-08-13 |
Not clear |
| Marlous C M van der Weijden, Dayana Rodriguez-Contreras, Cathérine C S Delnooz, Brooks G Robinson, Alec F Condon, Michelle L Kielhold, Gilles N Stormezand, Kai Yu Ma, Claudia Dufke, John T Williams, Kim A Neve, Marina A J Tijssen, Dineke S Verbee. A Gain-of-Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype. Movement disorders : official journal of the Movement Disorder Society. vol 36. issue 3. 2021-04-23. PMID:33200438. |
a gain-of-function variant in dopamine d2 receptor and progressive chorea and dystonia phenotype. |
2021-04-23 |
2023-08-13 |
Not clear |
| Marlous C M van der Weijden, Dayana Rodriguez-Contreras, Cathérine C S Delnooz, Brooks G Robinson, Alec F Condon, Michelle L Kielhold, Gilles N Stormezand, Kai Yu Ma, Claudia Dufke, John T Williams, Kim A Neve, Marina A J Tijssen, Dineke S Verbee. A Gain-of-Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype. Movement disorders : official journal of the Movement Disorder Society. vol 36. issue 3. 2021-04-23. PMID:33200438. |
we describe a 4-generation dutch pedigree with a unique dominantly inherited clinical phenotype of a combined progressive chorea and cervical dystonia carrying a novel heterozygous dopamine d2 receptor (drd2) variant. |
2021-04-23 |
2023-08-13 |
Not clear |
| Ichiro Kawahata, Kohji Fukunag. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia. International journal of molecular sciences. vol 21. issue 11. 2021-02-12. PMID:32471089. |
previous studies revealed that expression of the gene encoding nigrostriatal tyrosine hydroxylase (th), a rate-limiting enzyme of dopamine biosynthesis, is reduced in parkinson's disease and dopa-responsive dystonia; however, the mechanism of th depletion in these disorders remains unclear. |
2021-02-12 |
2023-08-13 |
Not clear |
| Eri Hayano, Mikito Shimizu, Kousuke Baba, Munehisa Shimamura, Tomokatsu Yoshida, Hideki Mochizuk. [A case of Alexander disease presented with dystonia of lower limb and decreased dopaminergic uptake in dopamine transporter scintigraphy]. Rinsho shinkeigaku = Clinical neurology. vol 60. issue 10. 2020-11-23. PMID:32893243. |
[a case of alexander disease presented with dystonia of lower limb and decreased dopaminergic uptake in dopamine transporter scintigraphy]. |
2020-11-23 |
2023-08-13 |
Not clear |
| Ryul Kim, Beomseok Jeon, Woong-Woo Le. A Systematic Review of Treatment Outcome in Patients with Dopa-responsive Dystonia (DRD) and DRD-Plus. Movement disorders clinical practice. vol 3. issue 5. 2020-10-01. PMID:30363598. |
dopa-responsive dystonia (drd) and drd-plus are inherited metabolic disorders of the dopamine synthetic pathway that have considerable clinical, biochemical, and genetic heterogeneity. |
2020-10-01 |
2023-08-13 |
Not clear |
| Eng Wee Chua, Simon P Harger, Martin A Kenned. Metoclopramide-Induced Acute Dystonic Reactions May Be Associated With the CYP2D6 Poor Metabolizer Status and Pregnancy-Related Hormonal Changes. Frontiers in pharmacology. vol 10. 2020-10-01. PMID:31507424. |
we theorize that cyp2d6 governs the risk of metoclopramide-related acute dystonia through its role in the synthesis of serotonin, which inhibits the dopamine tone. |
2020-10-01 |
2023-08-13 |
Not clear |
| Tars. Tardive Dyskinesia. Current treatment options in neurology. vol 2. issue 3. 2020-09-30. PMID:11096748. |
tetrabenazine and reserpine are presynaptic dopamine depletors that may have considerable efficacy in td, especially tardive dystonia; however, their use is often limited by side effects. |
2020-09-30 |
2023-08-12 |
Not clear |
| Bastien Ribot, Jérome Aupy, Marie Vidailhet, Joachim Mazère, Antonio Pisani, Erwan Bezard, Dominique Guehl, Pierre Burbau. Dystonia and dopamine: From phenomenology to pathophysiology. Progress in neurobiology. vol 182. 2020-09-10. PMID:31404592. |
dystonia and dopamine: from phenomenology to pathophysiology. |
2020-09-10 |
2023-08-13 |
Not clear |
| Bastien Ribot, Jérome Aupy, Marie Vidailhet, Joachim Mazère, Antonio Pisani, Erwan Bezard, Dominique Guehl, Pierre Burbau. Dystonia and dopamine: From phenomenology to pathophysiology. Progress in neurobiology. vol 182. 2020-09-10. PMID:31404592. |
however, the link between dystonia and dopamine appears complex and remains unclear. |
2020-09-10 |
2023-08-13 |
Not clear |
| Bastien Ribot, Jérome Aupy, Marie Vidailhet, Joachim Mazère, Antonio Pisani, Erwan Bezard, Dominique Guehl, Pierre Burbau. Dystonia and dopamine: From phenomenology to pathophysiology. Progress in neurobiology. vol 182. 2020-09-10. PMID:31404592. |
because dystonia is a disorder of motor routines, we first focus on the role of dopamine and striatum in procedural learning. |
2020-09-10 |
2023-08-13 |
Not clear |
| Bastien Ribot, Jérome Aupy, Marie Vidailhet, Joachim Mazère, Antonio Pisani, Erwan Bezard, Dominique Guehl, Pierre Burbau. Dystonia and dopamine: From phenomenology to pathophysiology. Progress in neurobiology. vol 182. 2020-09-10. PMID:31404592. |
search strategy and selection criteria references for this article were identified through searches in pubmed with the search terms « dystonia », « dopamine", « striatum », « basal ganglia », « imaging data », « animal model », « procedural learning », « pathophysiology », and « plasticity » from 1998 until 2018. |
2020-09-10 |
2023-08-13 |
Not clear |
| Aakash S Shetty, Kailash P Bhatia, Anthony E Lan. Dystonia and Parkinson's disease: What is the relationship? Neurobiology of disease. vol 132. 2020-07-27. PMID:31078682. |
the response of early dystonia to the introduction of dopamine replacement therapy (levodopa, dopamine agonists) is variable; dystonia commonly occurs in pd patients following levodopa initiation. |
2020-07-27 |
2023-08-13 |
Not clear |
| Aakash S Shetty, Kailash P Bhatia, Anthony E Lan. Dystonia and Parkinson's disease: What is the relationship? Neurobiology of disease. vol 132. 2020-07-27. PMID:31078682. |
pharmacological blockade of dopamine receptors can cause both tardive dystonia and parkinsonism and these movement disorders syndromes can occur in many other neurodegenerative, genetic, toxic and metabolic diseases. |
2020-07-27 |
2023-08-13 |
Not clear |